United States Biotechnology & Medical Research

PPD Inc (PPD)

Track

The most recent insider trading activity for PPD Inc. occurred on December 8, 2021. On this date, H&F Corporate Investors VII, Ltd. and H&F Corporate Investors VIII, Ltd. executed multiple large-scale sell transactions. No further insider trading activity has been reported since that time.
Ticker: PPD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
H&F Corporate Investors VII, Ltd.
9 sales — total 6,309,960,135 USD
Sale 8 Dec 2021
Value US$3,074,065.37 | Price 373.12 | Shares 29,687
Sale 8 Dec 2021
Value US$4,853,971.33 | Price 103.91 | Shares 11,812
Sale 8 Dec 2021
Value US$143,511,085.00 | Price 47.50 | Shares 3,021,286
Sale 8 Dec 2021
Value US$759,401,927.50 | Price 47.50 | Shares 15,987,409
Sale 8 Dec 2021
Value US$1,692,065,377.50 | Price 47.50 | Shares 35,622,429
Sale 8 Dec 2021
Value US$17,070,170.00 | Price 47.50 | Shares 359,372
Sale 8 Dec 2021
Value US$172,460,150.00 | Price 47.50 | Shares 3,630,740
Sale 8 Dec 2021
Value US$961,608,382.50 | Price 47.50 | Shares 20,244,387
Sale 8 Dec 2021
Value US$2,511,991,710.00 | Price 47.50 | Shares 52,884,036
Sale 8 Dec 2021
Value US$3,737,465.48 | Price 376.56 | Shares 26,804
Sale 8 Dec 2021
Value US$4,001,435.57 | Price 130.04 | Shares 79,879
Sale 8 Dec 2021
Value US$143,511,085.00 | Price 47.50 | Shares 3,021,286
Sale 8 Dec 2021
Value US$759,401,927.50 | Price 47.50 | Shares 15,987,409
Sale 8 Dec 2021
Value US$1,692,065,377.50 | Price 47.50 | Shares 35,622,429
Sale 8 Dec 2021
Value US$17,070,170.00 | Price 47.50 | Shares 359,372
Sale 8 Dec 2021
Value US$172,460,150.00 | Price 47.50 | Shares 3,630,740
Sale 8 Dec 2021
Value US$961,608,382.50 | Price 47.50 | Shares 20,244,387
Sale 8 Dec 2021
Value US$2,511,991,710.00 | Price 47.50 | Shares 52,884,036
Planned sale 14 Apr 2021
Value US$4,200,000.00 | Price 42.00 | Shares 100,000
Planned sale 17 Mar 2021
Value US$820,724.00 | Price 38.00 | Shares 21,598
Planned sale 17 Mar 2021
Value US$871,530.00 | Price 38.00 | Shares 22,935
Sale 3 Mar 2021
Value US$582,280.14 | Price 35.62 | Shares 16,347
Sale 2 Mar 2021
Value US$2,524,808.38 | Price 36.38 | Shares 69,401
Planned sale 2 Mar 2021
Value US$783,755.13 | Price 36.29 | Shares 21,597
Planned sale 1 Mar 2021
Value US$1,392,292.71 | Price 35.43 | Shares 39,297
Planned sale 12 Feb 2021
Value US$2,929,240.65 | Price 38.01 | Shares 77,065
Sale 29 Sep 2020
Value US$715,975.20 | Price 34.80 | Shares 20,574
Sale 29 Sep 2020
Value US$1,038,000.00 | Price 34.60 | Shares 30,000
Sale 22 Sep 2020
Value US$98,475.08 | Price 34.76 | Shares 2,833
Sale 21 Sep 2020
Value US$946,733.58 | Price 31.28 | Shares 30,264
Sale 21 Sep 2020
Value US$5,630,224.35 | Price 31.28 | Shares 179,980
Sale 21 Sep 2020
Value US$18,203,380.60 | Price 31.28 | Shares 581,903
Sale 21 Sep 2020
Value US$96,324,855.02 | Price 31.28 | Shares 3,079,193
Sale 21 Sep 2020
Value US$214,626,698.62 | Price 31.28 | Shares 6,860,919
Sale 21 Sep 2020
Value US$2,165,218.24 | Price 31.28 | Shares 69,215
Sale 21 Sep 2020
Value US$21,875,351.73 | Price 31.28 | Shares 699,284
Sale 21 Sep 2020
Value US$121,973,345.49 | Price 31.28 | Shares 3,899,092
Sale 21 Sep 2020
Value US$290,999,981.81 | Price 31.28 | Shares 9,302,325
Sale 21 Sep 2020
Value US$946,733.58 | Price 31.28 | Shares 30,264
Sale 21 Sep 2020
Value US$5,630,224.35 | Price 31.28 | Shares 179,980
Sale 21 Sep 2020
Value US$18,203,380.60 | Price 31.28 | Shares 581,903
Sale 21 Sep 2020
Value US$96,324,855.02 | Price 31.28 | Shares 3,079,193
Sale 21 Sep 2020
Value US$214,626,698.62 | Price 31.28 | Shares 6,860,919
Sale 21 Sep 2020
Value US$2,165,218.24 | Price 31.28 | Shares 69,215
Sale 21 Sep 2020
Value US$21,875,351.73 | Price 31.28 | Shares 699,284
Sale 21 Sep 2020
Value US$121,973,345.49 | Price 31.28 | Shares 3,899,092
Sale 21 Sep 2020
Value US$290,999,981.81 | Price 31.28 | Shares 9,302,325
Sale 21 Sep 2020
Value US$1,324,400.00 | Price 33.11 | Shares 40,000
Sale 21 Sep 2020
Value US$53,868.46 | Price 31.28 | Shares 1,722
Sale 21 Sep 2020
Value US$335,731,954.73 | Price 31.28 | Shares 10,732,261
Sale 18 Sep 2020
Value US$324,140.00 | Price 34.12 | Shares 9,500
Buy 10 Feb 2020
Value US$702,000.00 | Price 27.00 | Shares 26,000
Buy 10 Feb 2020
Value US$1,080,000.00 | Price 27.00 | Shares 40,000
Buy 10 Feb 2020
Value US$13,500.00 | Price 27.00 | Shares 500
Buy 10 Feb 2020
Value US$810,000.00 | Price 27.00 | Shares 30,000
Buy 10 Feb 2020
Value US$199,800.00 | Price 27.00 | Shares 7,400
Buy 10 Feb 2020
Value US$216,000.00 | Price 27.00 | Shares 8,000
Buy 10 Feb 2020
Value US$499,500.00 | Price 27.00 | Shares 18,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
29,687 +16.5%
373.12
US$3,074,065 		29,687 +16.5% 373.12 US$3,074,065
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
11,812 +40.6%
103.91
US$4,853,971 		11,812 +40.6% 103.91 US$4,853,971
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
8,579 -41.0%
243.67
US$3,393,254 		8,579 -41.0% 243.67 US$3,393,254
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
15,987,409 -100.0%
47.50
US$759,401,928 		15,987,409 -100.0% 47.50 US$759,401,928
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
35,622,429 -100.0%
47.50
US$1,692,065,378 		35,622,429 -100.0% 47.50 US$1,692,065,378
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
359,372 -100.0%
47.50
US$17,070,170 		359,372 -100.0% 47.50 US$17,070,170
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
3,630,740 -100.0%
47.50
US$172,460,150 		3,630,740 -100.0% 47.50 US$172,460,150
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
20,244,387 -100.0%
47.50
US$961,608,382 		20,244,387 -100.0% 47.50 US$961,608,382
2021-12-08 2021-12-08 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
52,884,036 -100.0%
47.50
US$2,511,991,710 		52,884,036 -100.0% 47.50 US$2,511,991,710
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
157,138 -100.0%
47.50
US$7,464,055 		157,138 -100.0% 47.50 US$7,464,055
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
934,469 -100.0%
47.50
US$44,387,278 		934,469 -100.0% 47.50 US$44,387,278
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,021,286 -100.0%
47.50
US$143,511,085 		3,021,286 -100.0% 47.50 US$143,511,085
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
15,987,409 -100.0%
47.50
US$759,401,928 		15,987,409 -100.0% 47.50 US$759,401,928
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
35,622,429 -100.0%
47.50
US$1,692,065,378 		35,622,429 -100.0% 47.50 US$1,692,065,378
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
359,372 -100.0%
47.50
US$17,070,170 		359,372 -100.0% 47.50 US$17,070,170
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,630,740 -100.0%
47.50
US$172,460,150 		3,630,740 -100.0% 47.50 US$172,460,150
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
20,244,387 -100.0%
47.50
US$961,608,382 		20,244,387 -100.0% 47.50 US$961,608,382
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
52,884,036 -100.0%
47.50
US$2,511,991,710 		52,884,036 -100.0% 47.50 US$2,511,991,710
2021-04-16 2021-04-14 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
100,000 -14.9%
42.00
US$4,200,000 		100,000 -14.9% 42.00 US$4,200,000
2021-03-18 2021-03-17 PlS Planned sale
Johnston David Michael

See Remarks

Officer
21,598 -37.9%
38.00
US$820,724 		21,598 -37.9% 38.00 US$820,724
2021-03-18 2021-03-17 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
22,935 -3.3%
38.00
US$871,530 		22,935 -3.3% 38.00 US$871,530
2021-03-05 2021-03-03 S Sale
Donovan Glen

Chief Accounting Officer

Officer
16,347 -84.5%
35.62
US$582,280 		16,347 -84.5% 35.62 US$582,280
2021-03-04 2021-03-02 S Sale
Garrow Ronald E

See Remarks

Officer
69,401 -100.0%
36.38
US$2,524,808 		69,401 -100.0% 36.38 US$2,524,808
2021-03-03 2021-03-02 PlS Planned sale
Johnston David Michael

See Remarks

Officer
21,597 -37.9%
36.29
US$783,755 		21,597 -37.9% 36.29 US$783,755
2021-03-03 2021-03-01 PlS Planned sale
Johnston David Michael

See Remarks

Officer
39,297 -52.6%
35.43
US$1,392,293 		39,297 -52.6% 35.43 US$1,392,293
2021-02-16 2021-02-12 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
77,065 -10.0%
38.01
US$2,929,241 		77,065 -10.0% 38.01 US$2,929,241
2020-10-01 2020-09-29 S Sale
Kaucic Karen

See Remarks

Officer
20,574 -71.0%
34.80
US$715,975 		20,574 -71.0% 34.80 US$715,975
2020-10-01 2020-09-29 S Sale
HARTMAN JUDD

See Remarks

Officer
30,000 -31.9%
34.60
US$1,038,000 		30,000 -31.9% 34.60 US$1,038,000
2020-09-24 2020-09-22 S Sale
Donovan Glen

Chief Accounting Officer

Officer
2,833 -48.6%
34.76
US$98,475 		2,833 -48.6% 34.76 US$98,475
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
30,264 -16.1%
31.28
US$946,734 		30,264 -16.1% 31.28 US$946,734
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
179,980 -16.1%
31.28
US$5,630,224 		179,980 -16.1% 31.28 US$5,630,224
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
581,903 -16.1%
31.28
US$18,203,381 		581,903 -16.1% 31.28 US$18,203,381
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
3,079,193 -16.1%
31.28
US$96,324,855 		3,079,193 -16.1% 31.28 US$96,324,855
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
6,860,919 -16.1%
31.28
US$214,626,699 		6,860,919 -16.1% 31.28 US$214,626,699
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
69,215 -16.1%
31.28
US$2,165,218 		69,215 -16.1% 31.28 US$2,165,218
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
699,284 -16.1%
31.28
US$21,875,352 		699,284 -16.1% 31.28 US$21,875,352
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
3,899,092 -16.1%
31.28
US$121,973,345 		3,899,092 -16.1% 31.28 US$121,973,345
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
30,264 -16.1%
31.28
US$946,734 		30,264 -16.1% 31.28 US$946,734
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
179,980 -16.1%
31.28
US$5,630,224 		179,980 -16.1% 31.28 US$5,630,224
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
581,903 -16.1%
31.28
US$18,203,381 		581,903 -16.1% 31.28 US$18,203,381
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,079,193 -16.1%
31.28
US$96,324,855 		3,079,193 -16.1% 31.28 US$96,324,855
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
6,860,919 -16.1%
31.28
US$214,626,699 		6,860,919 -16.1% 31.28 US$214,626,699
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
69,215 -16.1%
31.28
US$2,165,218 		69,215 -16.1% 31.28 US$2,165,218
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
699,284 -16.1%
31.28
US$21,875,352 		699,284 -16.1% 31.28 US$21,875,352
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,899,092 -16.1%
31.28
US$121,973,345 		3,899,092 -16.1% 31.28 US$121,973,345
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
9,302,325 -14.7%
31.28
US$290,999,982 		9,302,325 -14.7% 31.28 US$290,999,982
2020-09-23 2020-09-21 S Sale
Johnston David Michael

See Remarks

Officer
40,000 -43.0%
33.11
US$1,324,400 		40,000 -43.0% 33.11 US$1,324,400
2020-09-23 2020-09-21 S Sale
2.2
H&F Corporate Investors VII, Ltd.
Large shareholder
9,302,325 -14.7%
31.28
US$290,999,982 		9,302,325 -14.7% 31.28 US$290,999,982
2020-09-23 2020-09-21 S Sale
2.1
Hill Colin
Non-Executive Director
1,722 -10.8%
31.28
US$53,868 		1,722 -10.8% 31.28 US$53,868
2020-09-22 2020-09-21 S Sale
2.2
Carlyle Group Management L.L.C.
Large shareholder
10,732,261 -16.1%
31.28
US$335,731,955 		10,732,261 -16.1% 31.28 US$335,731,955
2020-09-22 2020-09-18 S Sale
Garrow Ronald E

See Remarks

Officer
9,500 -100.0%
34.12
US$324,140 		9,500 -100.0% 34.12 US$324,140
2020-02-12 2020-02-10 B Purchase
Scully Christopher G.

See Remarks

Officer
26,000 +inf%
27.00
US$702,000 		26,000 +inf% 27.00 US$702,000
2020-02-12 2020-02-10 B Purchase
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
40,000 +4.6%
27.00
US$1,080,000 		40,000 +4.6% 27.00 US$1,080,000
2020-02-12 2020-02-10 B Purchase
Donovan Glen

Chief Accounting Officer

Officer
500 +9.4%
27.00
US$13,500 		500 +9.4% 27.00 US$13,500
2020-02-12 2020-02-10 B Purchase
Sharbaugh William J

Chief Operating Officer

Officer
30,000 +9.0%
27.00
US$810,000 		30,000 +9.0% 27.00 US$810,000
2020-02-12 2020-02-10 B Purchase
Fikry Christopher

See Remarks

Officer
7,400 +111.4%
27.00
US$199,800 		7,400 +111.4% 27.00 US$199,800
2020-02-12 2020-02-10 B Purchase
2.7
Hilado Maria Teresa
Non-Executive Director
8,000 +31.4%
27.00
US$216,000 		8,000 +31.4% 27.00 US$216,000
2020-02-12 2020-02-10 B Purchase
2.4
KINDLER JEFFREY B
Non-Executive Director
18,500 +19.8%
27.00
US$499,500 		18,500 +19.8% 27.00 US$499,500
Explore more

More insider trading research around PPD Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America